Researchers at Neuralink, Elon Musk’s company, announced the start of a preliminary study of the effect of brain chips (BCIs) on humans, with the aim of exploring their ability to treat individuals paralyzed due to spinal cord injuries or amyotrophic lateral sclerosis.
BCIS systems have received the attention of world leaders in technology and medicine since they were adopted by Elon Musk, as these systems can interpret and translate brain signals, allowing control of external devices without physical intervention.
According to the company’s blog post, the initial study consists of three main components:
Slide N1: This chip is surgically implanted inside the brain and can capture and transmit neural activity.
According to the publication, the chip records neural activity on its 1,024 electrodes, distributed over 64 threads, each of which is as thin as a human hair.
Robot R1: The robot is used in performing the previous surgical procedure, as this robot was specially designed to place the N1 chip threads specifically in the intended area of the brain.
N1 chip users app: Neuralink launched the app with the aim of decoding a user’s intentions from the signals picked up by the N1 implant, allowing users to use computing devices using only their thoughts.
In addition to the above, the publication indicated that the study has specific criteria, as only participants who were paralyzed due to spinal cord injuries or amyotrophic lateral sclerosis (ALS) are accepted, provided that they have been paralyzed for at least a year without seeing any improvement, and that They must be at least 22 years old.
2023-09-24 15:49:00
#Neuralink #Beginning #initial #trials #brain #chip #humans #science #technology
